Icatibant Acetate API Market, Global Outlook and Forecast 2023-2030
Icatibant Acetate is the acetate salt form of icatibant, an antagonist of the human bradykinin B2 receptor (B2R), that can be used for the treatment of hereditary angioedema (HAE). Upon administration, icatibant targets and binds to B2R, thereby preventing bradykinin from binding to the B2R. This may prevent bradykinin/B2R-mediated vasodilation, the resulting increase in vascular permeability, and the swelling, inflammation, and pain associated with HAE. This may also prevent or improve pulmonary edema not associated with HAE and improve the associated decrease in blood oxygen levels.
This report aims to provide a comprehensive presentation of the global market for Icatibant Acetate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Icatibant Acetate API. This report contains market size and forecasts of Icatibant Acetate API in global, including the following market information:
Global Icatibant Acetate API Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Icatibant Acetate API Market Sales, 2018-2023, 2024-2030, (Ton)
Global top five Icatibant Acetate API companies in 2022 (%)
The global Icatibant Acetate API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity?98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Icatibant Acetate API include Dr. Reddy?s Laboratories Ltd., ChemWerth Inc, Bachem AG, Biophore India Pharmaceuticals Pvt. Ltd., Tecoland Corporation, Teva API and Sun Pharmaceutical Industries Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Icatibant Acetate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Icatibant Acetate API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Icatibant Acetate API Market Segment Percentages, by Type, 2022 (%)
Purity?98%
Purity<98%
Global Icatibant Acetate API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Icatibant Acetate API Market Segment Percentages, by Application, 2022 (%)
Icatibant Acetate Injections
Others
Global Icatibant Acetate API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Icatibant Acetate API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Icatibant Acetate API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Icatibant Acetate API revenues share in global market, 2022 (%)
Key companies Icatibant Acetate API sales in global market, 2018-2023 (Estimated), (Ton)
Key companies Icatibant Acetate API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Reddy?s Laboratories Ltd.
ChemWerth Inc
Bachem AG
Biophore India Pharmaceuticals Pvt. Ltd.
Tecoland Corporation
Teva API
Sun Pharmaceutical Industries Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Icatibant Acetate API, market overview.
Chapter 2: Global Icatibant Acetate API market size in revenue and volume.
Chapter 3: Detailed analysis of Icatibant Acetate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Icatibant Acetate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Icatibant Acetate API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
